International Journal of Antimicrobial Agents
Volume 35, Issue 5 , Page 514 , May 2010

In vitro activity of biapenem against Burkholderia pseudomallei

References 

  1. White NJ. Melioidosis. Lancet. 2003;361:1715–1722
  2. Dance DA, Wuthiekanun V, Chaowagul W, Suputtamongkol Y, White NJ. Development of resistance to ceftazidime and co-amoxiclav in Pseudomonas pseudomallei. J Antimicrob Chemother. 1991;28:321–324
  3. Wuthiekanun V, Cheng AC, Chierakul W, Amornchai P, Limmathurotsakul D, Chaowagul W, et al. Trimethoprim/sulfamethoxazole resistance in clinical isolates of Burkholderia pseudomallei. J Antimicrob Chemother. 2005;55:1029–1031
  4. Perry CM, Ibbotson T. Biapenem. Drugs. 2002;62:2221–2234
  5. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; approved standard. Fifteenth informational supplement. Document M100-S15. Wayne, PA: CLSI; 2005.

PII: S0924-8579(10)00016-6

doi: 10.1016/j.ijantimicag.2010.01.002

International Journal of Antimicrobial Agents
Volume 35, Issue 5 , Page 514 , May 2010

Article Tools